NCCN® 2019 in San Francisco: Latest Treatment Innovations for Hematologic Malignancies

Sep 11, 2019 | Blood Cancer, Conference, Congress, Hematology, NCCN

NCCN® 2019 in San Francisco: Latest Treatment Innovations for Hematologic Malignancies

World-renowned experts on blood cancers are meeting in San Francisco on September 27-28 to help clinicians stay up-to-date on new, practice changing strategies to manage patients with hematologic malignancies at the NCCN 2019 Annual Congress: Hematologic Malignancies™ presented by the National Comprehensive Cancer Network® (NCCN®), and co-chaired by Ranjana H. Advani, MD, Saul Rosenberg Professor of Lymphoma, Stanford University School of Medicine and Andrew D. Zelenetz, MD, PhD, Medical Director, Quality Informatics, Memorial Sloan Kettering Cancer Center. 

The Congress will address new, emerging, and novel therapeutic agents, diagnostics, and other advances in the management of blood cancers. Participants will also explore the growing role of immunotherapies, biosimilars, personalized medicine, and chemotherapeutic options in a rapidly-changing landscape.

The congress takes place at the Hilton San Francisco Union Square, and features the following faculty:

Jeremy S. Abramson, MDMassachusetts General Hospital Cancer Center

Muhamed Baljevic, MDUniversity of Nebraska Medical Center, Fred & Pamela Buffett Cancer Center

Rafael Bejar, MD, PhDUC San Diego Moores Cancer Center

Jennifer R. Brown, MD, PhDDana-Farber Cancer Institute

Jorge J. Castillo, MDDana-Farber Cancer Institute

Mrinal Dutia, MDThe Permanente Medical Group

Yvonne A. Efebera, MD, MPHThe Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute

Richard I. Fisher, MDFox Chase Cancer Center

Michael M. Green, MDKaiser Permanente

Jarrod Holmes, MDAnnadel Medical Group

Michaela Liedtke, MDStanford Cancer Institute

Thomas G. Martin III, MDUCSF Helen Diller Family Comprehensive Cancer Center

Nitin Jain, MDThe University of Texas MD Anderson Cancer Center

Jae Park, MDMemorial Sloan Kettering Cancer Center

Daniel A. Pollyea, MD, MSUniversity of Colorado Cancer Center

Noopur S. Raje, MDMassachusetts General Hospital Cancer Center

William G. Wierda, MD, PhDThe University of Texas MD Anderson Cancer Center

There is also a pre-congress session for nurses, which includes presentations on how to prevent infections in hematologic malignancies, managing bone health in patients with multiple myeloma, tumor lysis syndrome updates, and managing toxicities related to CAR T-Cell therapy. The forum features the following speakers:

Colleen H. Erb, MSN, CRNP, ACNP-BC, AOCNPAbramson Cancer Center at the University of Pennsylvania

Yi Lisa Hwa, APRN, CNP, DNPMayo Clinic Cancer Center

Lauren N. Spendley, MSN, AGNP-BC, AOCNDana-Farber Cancer Institute

Laura J. Zitella, MS, RN, ACNP-BC, AOCNUCSF Helen Diller Family Comprehensive Cancer Center

Follow the link below to the press release. Also see media contacts below.

Clinicians, visit Patients and caregivers, visit Media, visit Follow NCCN on Twitter @NCCN, Facebook @NCCNorg, and Instagram @NCCNorg.

Media Contact:
Rachel Darwin


Pin It on Pinterest